Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the sensitivity and specificity of protein detection. Although the CRISPR/Cas system has made remarkable progress in nucleic acid detection, in terms of protein detection, the existing methods can usually only achieve femtomolar - picomolar level sensitivity, which is far from meeting the needs of many applications in biology, medicine and the food industry, especially in disease diagnosis and prognosis, such as the detection of cancer, Alzheimer's disease and cardiovascular diseases. Therefore, researchers have developed a new technology named CRISPR - AMPED, which uses the CRISPR/Cas system to achieve ultrasensitive protein detection by combining magnetic proximity extension and detection. Specifically, the CRISPR - AMPED technology improves the sensitivity of protein detection through the following steps: 1. **Magnetic Proximity Extension**: First, use magnetic bead - labeled capture antibodies to bind to the target protein, and then add a pair of detection antibodies labeled with DNA probes (i.e., PEA probes). The target protein - antibody complex stabilizes the hybridization between DNA probes, enabling these probes to be extended into double - stranded DNA sequences with the help of Bst polymerase. The use of magnetic beads allows for thorough washing to reduce non - specific binding and hybridization, thereby reducing background noise and increasing detection sensitivity. 2. **Isothermal Nucleic Acid Amplification Test (NAAT)**: The generated double - stranded DNA sequences are amplified by recombinase polymerase amplification (RPA) and fluorescently detected using the CRISPR/Cas12a system. This process does not require thermal cycling and large - scale equipment, reduces amplification time, and provides synchronous amplification of the target and signal, thereby significantly improving detection sensitivity. Finally, CRISPR - AMPED achieves attomolar - level sensitivity, which is more than three orders of magnitude higher than the traditional ELISA method and is superior to the existing CRISPR/Cas - based detection systems. In addition, the study also shows the potential of smartphone - based detection devices in point - of - care (POC) testing, and the application in digital format expands the dynamic range of detection and improves quantitative accuracy. These features make CRISPR - AMPED an important advancement in the field of protein detection.

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

Universal CRISPR/Cas12a-associated aptasensor suitable for rapid detection of small proteins with a plate reader

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Aptamer-Linked CRISPR/Cas12a-Based Immunoassay

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Ultrafast Visual Nucleic Acid Detection with CRISPR/Cas12a and Rapid PCR in Single Capillary

Reagents-Loaded, Automated Assay that Integrates Recombinase-Aided Amplification and Cas12a Nucleic Acid Detection for a Point-of-Care Test

Amplification-free nucleic acids detection with next-generation CRISPR/dx systems

Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12a

CRISPR/Cas12a-Powered Competitive Immunosorbent Assay for Small Molecules

Designing a CRISPR/Cas12a- and Au-Nanobeacon-Based Diagnostic Biosensor Enabling Direct, Rapid, and Sensitive miRNA Detection

Amplification-free CRISPR/Cas detection technology: challenges, strategies, and perspectives.

Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer

One-Pot Detection of Proteins Using a Two-Way Extension-Based Assay with Cas12a

Nanozyme-assisted amplification-free CRISPR/Cas system realizes visual detection

Harnessing the CRISPR-Cas13d System for Protein Detection by Dual-Aptamer-Based Transcription Amplification

Holographic Optical Tweezers and Boosting Upconversion Luminescent Resonance Energy Transfer Combined Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas12a Biosensors

Biosensing bacterial 16S rDNA by microchip electrophoresis combined with a CRISPR system based on real-time crRNA/Cas12a formation